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Abstract
In recent years, the number of human infection cases produced by the food related species
Saccharomyces cerevisiae has increased. Whereas many strains of this species are consid-
ered safe, other ‘opportunistic’ strains show a high degree of potential virulence attributes
and can cause infections in immunocompromised patients. Here we studied the genetic
characteristics of selected opportunistic strains isolated from dietary supplements and also
from patients by array comparative genomic hybridization. Our results show increased copy
numbers of IMD genes in opportunistic strains, which are implicated in the de novo biosyn-
thesis of the purine nucleotides pathway. The importance of this pathway for virulence of
S. cerevisiae was confirmed by infections in immunodeficient murine models using aGUA1
mutant, a key gene of this pathway. We show that exogenous guanine, an end product of
this pathway in its triphosphorylated form, increases the survival of yeast strains in ex vivo
blood infections. Finally, we show the importance of the DNA damage response that acti-
vates dNTP biosynthesis in yeast cells during ex vivo blood infections. We conclude that op-
portunistic yeasts may use an enhanced de novo biosynthesis of the purine nucleotides
pathway to increase survival and favor infections in the host.
Introduction
The yeast Saccharomyces cerevisiae can be found naturally in many niches in the environment,
but it is most commonly known for its role as “baker’s yeast” in either the traditional or indus-
trial fermentative production of bread, beer or wine. It can be found in many dietary
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supplements as the main component and a part of these yeast cells are alive. It has also been
used as a nutritional supplement and as an agent to treat antibiotic-related diarrhea, commer-
cialized as Saccharomyces boulardii [1]. Classically, S. cerevisiae has been considered a non-
pathogenic and safe organism. However, in the last few years, cases of diagnosed S. cerevisiae
infections have increased, probably due to an increase in the numbers of immunocompromised
patients and the progress made in diagnostic methodologies, including microbial identification
by molecular techniques. S. cerevisiae has been identified in a wide variety of infections, ranging
from cutaneous infections and vaginitis in healthy individuals, to systemic bloodstream infec-
tions and infections of vital organs in immunocompromised and critically ill patients [1–3].
Infected patients are premature children, elderly people or patients suffering from immuno-
suppression due to AIDS, treatment with immunosuppressive agents, or other conditions asso-
ciated with an insufficient immune response. Moreover, severe infections with S. cerevisiae
have been occasionally reported in patients with no obvious predisposing factors [4,5]. All
these data have changed the status of S. cerevisiae, which is now considered to be an emerging
opportunistic pathogen [6–9]. Several studies have analyzed the potential virulence of this
yeast species in vitro [10–13], while others have used in vivomodels [13–17]. These reports
suggest that some clinical, but also non-clinical, S. cerevisiae strains have the potential to cause
disease in murine models regardless of the host’s immune status.
To elucidate the genetic determinants that influence the ability of S. cerevisiae to cause infec-
tion, we selected strains that showed high levels of virulence attributes (pseudohyphal and
growth at 42°C, phosphatases and proteases secretion, and the ability to infect and kill mice)
independently of the isolation origin [13], [16], [18], and we used these strains for a compara-
tive genetics approach. We observed increased copy number (CN) of the genes related to the de
novo biosynthesis of the purine nucleotides pathway. One of the key genes of this pathway,
which encodes an enzyme catalyzing the second pathway step, is GUA1. The importance of
this pathway for virulence of S. cerevisiae was confirmed by experimental infections in immu-
nodeficient murine models using a Δgua1mutant of the clinical strain D14, isolated from a
dietary product. We also revealed that exogenous guanine, an end product of the purine nucle-
otides pathway in its triphosphorylated form, increases the survival of yeast strains in ex vivo
blood infections. Finally, we show the implication of the DNA damage checkpoint that acti-
vates dNTP biosynthesis in yeast cells during blood infections. We conclude that opportunistic
yeasts may use an enhanced de novo biosynthesis of the purine nucleotides pathway to counter-
act the immune system of the host. An increased efficiency of dNTP biosynthesis may in turn
promote DNA repair after DNA damage produced by neutrophil oxidative bursts.
Materials and Methods
Yeast strains and media
Several S. cerevisiae isolates were used in this work: a clinical vaginal isolate (isolate 60), an iso-
late from the respiratory tract (isolate 102) [10], a brewer’s strain isolated from a commercial
nutritional complement product (D14) [13], auxotrophic laboratory strains W303 (MATa;
ura3-52; trp1Δ2; leu2-3,112; his3-11; ade2-1; can1-100), BY4741 (MATahis3Δ0 leu2Δ0
met15Δ0 ura3Δ, Open Biosystems), Δdun1 (MATa his3Δ0 leu2Δ0met15Δ0 ura3Δ, Open Bio-
systems), W1588-4C (MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 RAD5) (31),
rnr1 (MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 RAD5 rnr1-W688G) [19]
and prototrophic strain S288C (MATα SUC2 gal2 mal mel flo1 flo8-1 hap1). Isolates 102, 60
and D14 were chosen from a yeast collection of potential pathogenic isolates obtained mainly
from hospitals, but also from commercial dietary products [16], [18]. These isolates were pro-
posed to have a higher virulence potential since they showed increased pseudohyphal and 42°C
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growth [18], augmented phosphatases and proteases secretion [18] and were able to survive
and to colonize in the brain and kidney of immunocompetent mice after blood infections,
thereby causing morbidity and death among their hosts [13], [16]. In addition, strains 60
and D14 were less efficiently phagocytized by macrophages as compared to other strains [13].
S. cerevisiae strains were cultured in YPD (1.0% yeast extract, 1.0% Bacto-peptone and 2.0%
glucose) and in SC medium (5.6% YNB without amino acids, 1.3% complete amino acid drop
out (Formedium, UK)). The corresponding media were supplemented with CuSO4 (0–2.0
mM) and also mycophenolic acid (MPA) (7 μg/ml) or methyl methanesulfonate (MMS)
(0.004%) or guanine (25 μM) based on previously reported methods [20–22].
The mutant D14Δgua1 was obtained by a PCR-based gene-replacement strategy using the
subsequent deletion cassettes containing geneticin or hygromycin resistance [23]. The primers
used had 40 bp homologous to the gene coding sequence at their 5’ or 3’ end. The amplified
PCR products were used for gene disruption, performed by homologous recombination follow-
ing yeast transformation using the lithium acetate procedure. The PCR reactions were as fol-
lows: 2 min at 94°C; 30 cycles of 15 s at 94°C, 30 s at 50°C, 2 min at 72°C and 5 min at 72°C.
Cells were transformed with the PCR product following the LiAc protocol (http://home.cc.
umanitoba.ca/~gietz/website). After heat shock, cells were incubated for 3 h in YPD liquid me-
dium at 30°C. Finally, transformed cells were selected on YPD plates with geneticin (200 mg/L)
or hygromycin. GUA1 gene deletion was confirmed by a PCR analysis and guanine auxotrophy.
Strain D14GUA1 was obtained by transforming strain D14Δgua1 with a plasmid containing a
wild-type copy of GUA1 (pGUA1) and by selecting in YPD with 200 μg/mL of G418 (Sigma).
The plasmid obtained from Iglesias-Gato et al. [21] was marker-swapped for KANMX by ho-
mologous recombination using a cassette obtained by PCR and a pUG6 plasmid as a template.
Yeast growth in the presence of copper salt (0, 0.5, 1 and 2 mM of CuSO4) was quantified in
microtiter plates on a reader model POLARstar Optima (BGM Labtech, Offenburg, Germany).
Wells were filled with the appropriate number of yeast cells and 0.5 ml of YPD medium (with
or without copper salt) to reach an initial OD of approximately 0.2 (corresponding to a starting
cell number of*106 cells/ml). Non-inoculated wells were included for each experimental se-
ries to determine, and consequently subtract, noise signals. Growth was monitored by optical
density (OD) changes at a wavelength of 600 nm. Measurements were taken every 30 min for
72 h at 28°C (until yeast cells reached the stationary phase) after a 20-second pre-shaking. All
experiments were carried out in triplicate and maximal OD was obtained for each condition.
DNA labeling and competitive genome hybridization
DNA was extracted from yeast strains grown from single colonies in YPD medium following
the procedure described by Belloch et al [23]. Before the labeling reaction, 4 μg of DNA were
treated with RNAse A (1 mg/mL, Roche Diagnostics) for 1 h at 37°C and with Proteinase K (1
mg/ml, Quiagen) for 1.5 h at 37°C with agitation. Phenol extracted DNA was digested with
MseI or RsaI (New England Biolabs, Inc.), according to the manufacturer's instructions, and di-
gestions were mixed. The fragmented sample was purified using the QIA-quick gel extraction
kit (Qiagen, Germany), heat denatured for 5 min at 100°C, and then cooled on ice. DNA was
labeled in 21-μl reaction mixtures by random priming using the BioPrime Array CGH Geno-
mic Labeling System (Invitrogen). Unincorporated nucleotides are removed by filtration
through a Qiaquick PCR Purification column (Qiagen). Equal amounts of labeled DNA (1μ)
were used as probes to hybridize to the PCR-amplified open reading frames (ORFs) of homo-
ploid S. cerevisiae S288C DNA spotted onto microarrays (Eurogentec S.A., Belgium). Microar-
rays were pre-hybridized with 5 ml of pre-hybridization solution (3× SSC (1× SSC is 0.15 M
NaCl plus 0.015 M sodium citrate), 0.1% SDS, and 0.1 mg/ml BSA) at 42°C for 1 h. After
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washing slides with isopropanol and water, samples were centrifuged at 1300 rpm for 10 min
at room temp. Then 10 μl of samples and 50 μl of hybridization solution (50% (v/v) formamide,
5x SSC, 0.1% SDS and 0.1 mg/ml DNA from salmon sperm) were denatured (95°C, 1 min) and
added to the slides that were incubated for 16 h at 42°C in a Gene Machines Hyb Chamber (Ge-
nomic Solutions). Slides were recovered and washed 5 min at 42°C in 1 (2x SSC, 0.1% SDS),
2x10 min in solution 2 (0.1 x SSC, 0.1% SDS), 5x1min in solution 3 (0.1 x SSC) and 5 s in solu-
tion 4 (0.01 x SSC). Slides were centrifuged for 10 min at 1300 rpm.
Microarray scanning and data normalization
Images were acquired using GenePix 4100A (Axon Instruments, Molecular Devices Corp.,
USA) with a 10-μm resolution using the GenePix Pro 6.1 software (Axon Instruments, Molecu-
lar Devices Corp., USA). Raw data were processed using Acuity 4.0 (Axon Instruments, Molec-
ular Devices Corp., USA). All the slide data were normalized with a log2(ratio) average and
filtered (signal of each channel> 350 and signal/noise ratio> 2.5). Poor or inconsistent signals
were not considered for further analysis. Hybridization signals were depicted as the log2 hy-
bridization signal ratio. Genomic material obtained from three biological independent repli-
cates was used to perform hybridizations two or three times, including a dye-swap, and the
genes with signal intensities ± 0.5 were considered for further analysis. FDR<0.05 was used to
select significant data. Heat map was generated in MeV 4.9 software using developers instruc-
tions were each row represents a specific gene and each column represents each strain. The
lightest green boxes are the most underrepresented genes and the brightest red being the most
overrepresented genes.
Flow cytometry
Yeasts strains were grown in 10 ml of YPD liquid medium under agitation. Early-stationary-
phase cells (106 cells ml−1) were harvested by centrifugation, washed and fixed in 70% ethanol
at 4°C for 5 min. Fixed cells were harvested by centrifugation and resuspended in 0.01 M phos-
phate-buffered saline buffer (pH 7.2) containing 400 μl of RNase (10 mg ml−1). After incuba-
tion at 37°C for 30 min, cells were harvested by centrifugation and re-suspended in 950 μl of
0.01 M phosphate-buffered saline buffer (pH 7.2) containing 50 μl of propidium iodide
(0.005%). Samples were analyzed using a flow cytometer FACScan analyzer (Becton Dickin-
son). DNA content values were scored on the basis of the fluorescence intensity of the first
peak by comparing with the haploid W303 and diploid S288c strains.
qRT-PCR
To validate the microarrays results, the DNA from the five strains was isolated and the copy
number of the three genes was quantified. The genes selected were IMD2, IMD3 and SAM3
with criteria explained below. qRT-PCR was performed with gene-specific primers (200 nM)
(IMD2-F: AACATTCCTGTCAAGACATCGG, IMD2-R: TCAGTTATGTAAACGCTTTTCGTAA,
IMD3-F: CGGTTTACAACATTCTTGTCAAGAC, IMD3-R: AAACGCTTTTCGTAAGAATG-
TAAGT, SAM3-F: GCGGGTGAAATATACGTATCGG, SAM3-R: ATTCTCCACGGAACACC-
CAGTA, ACT1F: TACAACTCCATCATGAAGTG and ACT1-R: GCCAAAGCGGTGATTTCC) in a
20 μl reaction using Light Cycler Fast Start DNAMaster PLUS SYBR green (Roche Applied
Science, Germany) in a LightCycler 2.0 System (Roche Applied Science, Germany) device. All
the samples were processed for the melting curve analysis, amplification efficiency and DNA
concentration determination using the LightCycler 2.0 System. A mix of all the samples and se-
rial dilutions (10-1 to 10-5) was utilized as the standard curve. Data were normalized with the
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ACT1 gene to correct for the DNA content in each sample. Data are presented as the
average ± standard deviations of three biological replicates.
Experimental infection
S. cerevisiae strains were grown at 30°C on YPD. After 24 h, cells were harvested, washed twice
with sterile phosphate-buffered saline (PBS) and diluted to the desired density. Healthy mice
were infected by intravenous inoculation into the tail vein with 2 × 107 viable CFU of yeast in a
0.2-ml volume of PBS, as previously described [15]. Twenty-four DBA/2 mice, aged 7–8 weeks,
were respectively used (8 mice per S. cerevisiae strain). Mice were housed in groups of five in
individually ventilated cages and cared for in strict accordance with the principles outlined in
the European Convention for the Protection of Vertebrate Animals Used for Experimental and
Other Scientific Purposes (http://conventions.coe.int/Treaty/en/Treaties/Html/123.htm).
Experiments were approved by the governmental ethics committee (Comité Ético de Experi-
mentación Animal, Universitat de Valencia). Neutropenia in mice was produced by an intra-
peritoneal injection of 150 mg/kg of cyclophosphamide (Sigma-Aldrich) 1 day before
inoculation with each S. cerevisiae strain. Five days later, all the animals received a second dose
of cyclophosphamide (150 mg/kg) to maintain neutropenia until the end of the assay. Similar
treatments have demonstrated that severe neutropenia can be achieved and maintained [24].
The infected animals were visually monitored at least twice daily and they were humanely eu-
thanized by cervical dislocation when any apparent signs of suffering were found. Mouse sur-
vival was analyzed by using Kaplan-Meyer curves and the log-rank test. No adverse events
occurred during the assay.
Survival assay in human blood
To investigate the survival of yeast strains in blood we used the method previously described
[25]. Yeast strains were grown overnight in YPD medium at 30°C. Cells were washed once and
suspended in PBS buffer (phosphate-buffered saline: 150 mM NaCl, 16 mM Na2HPO4, 4 mM
NaH2PO4, pH 7.4) at a density of 5 x 10
7 cells/ml. Human peripheral venous blood was collect-
ed from healthy volunteers by venipuncture using ammonium heparin syringes (Monovette,
Sarstedt) as described [25]. Blood was obtained from healthy human donors with written in-
formed consent. The blood donation protocol and use of blood for this study were approved by
the institutional ethics committee (Comité Ético del Insituto de Agroquímica y Técnología de
los Alimentos, CSIC). After leukocyte count with Neubauer chamber, yeast cells were inoculat-
ed (1:1 ratio of yeast:leukocytes) in blood and incubated for 90 min at 37°C as described [25].
Then, 100 μl of the 10-3 to 10-4dilutions were spread on YPD plates and incubated for 48 h at
30°C. Colony-forming units (cfu) were counted and relative percentages of survival were deter-
mined as follows: (((cfu/cfut = 0))/((cfu/cfut = 0)control)100)-100. To avoid effects of individual
blood differences, survival was normalized to the reference strain included in each set of experi-
ments. Each strain was tested 3 times. Data were represented as averages ± standard deviations.
Results
Virulent strains of S. cerevisiaemust have specific attributes which contribute to their potential
to cause opportunistic infections. To search for specific features of virulent strains of S. cerevi-
siae, we studied their genome structures by microarray CGH. This technique allowed us to iden-
tify those genes with copy number variations (CNV) in the opportunistic strains compared with
non-virulent strains. We selected three different opportunistic S. cerevisiae strains (D14, 60,
102) which have been shown to exhibit high levels of virulence in vitro and in vivo, presented
enhanced survival rates in blood, increased burdens in brain and kidney, and were able to kill
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mice [13], [16], [18]. Since the ploidy of the different strains is important for interpreting CGH
data, we analyzed ploidy by flow cytometry. The results suggested that strains 102 (2.00 ± 0.07)
and D14 (2.16 ± 0.07) are diploids (considering 20% deviation plausible due to experimental
error), whereas the result of strain 60 (2.41 ± 0.05) indicate that it is a diploid strain with addi-
tional copies of some chromosomes. The labeled DNA from the four strains was hybridized
with DNA from control strain S288C to a standard cDNAmicroarray containing cDNA of the
S288C genome. The signals obtained were filtered and normalized. The whole dataset is deposit-
ed in GEO Database (accession number GSE53440) using standard MIAME criteria.
Comparative genomic hybridization of opportunistic strains
When we analyzed the CGH data in a genome-wide graph with all the strains, including con-
trol strain W303 (Fig. 1A), we observed a significant amount of CNV in the subtelomeric re-
gions (22.8%). When we analyzed the absolute signal intensity of the genes in relation to the
distances to telomeres (Fig. 1B), we observed that CNV significantly accumulated in the first
30 kb, which matches the subtelomeric region. The sliding window analysis, which averaged
signal intensity (1 Kb), also revealed a significant increase in the subtelomeric region. These
observations are consistent with previous CGH studies which compared the genome of S. cer-
evisiae strains of different origins [26], [27]. As expected, W303, whose genome is 85%
isogenic to S288C [28], was the strain that showed less CN (50) as compared to the opportu-
nistic strains D14 (180), 102 (334) and 60 (430),with differences found mainly in the number
of increased CN (Fig. 1C). To confirm these data, we tested for the presence of W303 in the
sequenced genome (www.yeastgenome.org) of the first 25 genes with less relative intensity
data, and most of them [28] were absent. These results also confirmed that some genes, previ-
ously described as highly variable among strains of different sources [26], [27], for example,
members of the PAU,MAL, AAD and FLO gene families, the ASP3 and ENA clusters, the
SNO/SNZ and SOR/MPH genes and other genes, i.e., DAK2 or AGP3, showed altered CN in
opportunistic strains. Among these genes, whose numbers had increased in opportunistic
strains, we found several genes related to DNA damage repair, such as DDR48, CAC2 and
RRD1 in strain 102 and RAD18, POL4,MSH2 and IMP2 in strain 60. One interesting result
was the strong increase in the CNV of PRB1, which encodes a protease whose protein abun-
dance increased after DNA damage in strains 60 and 102. Another observation was the in-
crease in the CNV for gene YAR068W. An overexpression of this uncharacterized gene has
been seen causing enhanced resistance to antifungal drugs, such as ketoconazole, miconazole
and benomyl [29].
We searched for genes with CNV in all investigated strains and found that 45 genes were
common for the opportunistic yeasts (Fig. 1D). A hierarchical clustering of this core set of
CNV-enriched genes (Fig. 2A) revealed a clear difference between opportunistic and laborato-
ry strains. All except 14 transposon genes and two other genes, the genes showed opposite or
different CNV values in the opportunistic strains as compared to W303. Twenty-seven of
these 45 genes presented decreased CN, and four increased and 14 variable values among the
different strains. Interestingly, 31.1% of the core genes were transposons, a fact that reflects
one of the most important differences observed when comparing genomes of different strains.
Next, we focused on those genes showing an altered CN in the opportunistic strains when
compared to laboratory strains. Among this group of genes, we focused our study on the
CUP1 cluster, which displayed a decreased CN in the opportunistic strains when compared
with laboratory strains. The SAM cluster and IMD2 had an increased CN in the opportunistic
strains vs. laboratory strains.
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Fig 1. Comparative genomic hybrization of opportunistic strains.D14, 60 and 102 were compared to laboratory strain W303 hybridizing DNA to S288C
cDNAmicroarray. A) Log2 of normalized and filtered data of the four strains is represented according its chromosomal disposition in stack bar graph. Specific
genes are depicted with an arrow. B) Absolute signal intensity of genes is represented against distance to telomere. Discontinuous line represents sliding
window average (10x) of values in 1 Kbp. C) Number of genes in increased or decreased CNV represented for each strain. D) Venn diagram showing the
number of specific or common genes for strains D14, 103 and 60. E) Local zoom of general graph presented in A) for genes IMD3, IMD2 andCUP1
chromosomal regions for opportunistic strains.
doi:10.1371/journal.pone.0122382.g001
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Fig 2. Opportunistic strains showed altered CN of specific genes. A) Genes that showed altered CNV in the three opportunistic strains were clustered
and the heat map obtained (Mev software) is represented. B) Evaluation of growth with different concentrations of copper was performed in microtiter plates
in YPDmedia. Maximal growth for each Cu concentration was relativized to YPD without Cu for each strain. Average and standard deviation of triplicates is
represented C) Gene copy number was determined by qPCR. Data was normalized with haploid strain S288C. Average and standard deviation of triplicates
is represented. D) Heat map detail of genes that belong to de novo purine biosynthetic pathway (Mev software).
doi:10.1371/journal.pone.0122382.g002
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Genetic variability in the CUP1 cluster
The CUP1 cluster contains a duplication of the CUP1 gene flanking an uncharacterized ORF
(CUP1-1, YHR054C and CUP1-2). This cluster shows a decreased CN in the opportunistic
strains when compared with laboratory strains (Fig. 1E). High variability in CN has been de-
scribed for this cluster, which is probably the result of recombination events between duplicates
[27]. Since the gene copy number correlates with Cu resistance [30], we studied the growth of
both, the opportunistic strains and W303, in minimal media with a Cu concentration range in
order to validate the CGH analysis with phenotypical data. The results obtained (Fig. 2B) con-
firm the CGH data as none of the opportunistic strains was able to grow, not even at the lowest
Cu concentration. Conversely, lab strain W303, which has a larger number of CUP1 copies,
was able to grow with 1 mM of Cu.
Alteration in S-adenosylmethionine metabolic genes
Two of the genes with an increased CN in the opportunistic S. cerevisiae strains were SAM3
and SAM4, which encode a high-affinity S-adenosylmethionine (SAM) permease and an
S-adenosylmethionine-homocysteine methyltransferase, respectively. We studied the genomic
content of SAM3 in the different strains with qPCR in more detail (Fig. 2C). The results con-
firm the CGH data and suggest at least one more copy of the gene in strain D14 and two more
copies in strains 60 and 102, whereas no variation was observed in haploid strain W303.
These enzymes are involved in the utilization of SAM as a sulfur source, and also in glutathione
(GSH) biosynthesis, which is the main antioxidant molecule in yeast cells. As the oxidative
stress response is very important for opportunistic yeasts to survive in human blood, we stud-
ied if these strains were capable of increasing the GSH content using SAM as a sulfur source.
However, no differences were observed (results not shown). In fact, SAM3 and SAM4 are locat-
ed in a subtelomeric cluster that has been shown to have higher CNs in other strains [31].
Therefore, we cannot rule out that this genomic alteration is not a specific feature of the
opportunistic strains.
Genetic changes in the de novo purine nucleotides biosynthetic pathway
We focused our study on IMD2, a gene showing increased CNs in the three opportunistic
strains compared with laboratory strains (Fig. 2A). This gene belongs to the IMD gene family
(IMD1-4), which code for Inosine monophosphate dehydrogenases (IMD), enzymes which
catalyzes the rate-limiting step in the de novo GTP biosynthetic pathway. We confirmed the in-
creased CNs of IMD2 by qPCR, and showed at least two more copies of the gene in strain 102
and three more copies in strains 60 and D14 (Fig. 2C). Similar alterations were monitored for
its closely related gene, IMD3, where increased CN was observed in strains 102 and D14
(Fig. 2A), but not in strain 60. These results were also confirmed by qPCR, showing at least one
more copy of IMD3 in strains 102 and D14 (Fig. 2C). No signal was detected for IMD3 amplifi-
cation in strain 60.
We wondered if the increased CNs observed for the IMD genes in the opportunistic strains
could be a result of their adaptation or ability to survive in human environments and whether
this could be associated with their ability to cause infections. IMD2 is a subtelomeric gene,
which has been correlated with altered CNs in strains of different origins. In fact, other genes
located next to IMD2 exhibit CNVs (Fig. 1E). In contrast, IMD3 is localized at the right arm of
chromosome XII and is not close to any ribosomal genes, transposons or any other genomic
feature that are known to favor recombination or genome rearrangements. Furthermore, no
other genes close to IMD3 have been shown to have altered CNs (Fig. 1E). We studied the
CNVs of the other genes implicated in the de novo biosynthesis of the purine nucleotides
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pathway (Fig. 2D) and we observed increased CN for other genes, such as GUK1 in strain 60
and RNR4 in 102. No significant increased CN was observed in the W303 strain and no signifi-
cant decrease in any gene related to the purine nucleotides pathway was found. All these data
suggest that this pathway might be of special importance for the opportunistic strains to devel-
op their specific abilities.
In order to test the role of the de novo biosynthesis of the purine nucleotides pathway in
S. cerevisiae virulence, we wanted to construct a knock out mutant that is unable to use this
pathway within the genetic background of the opportunistic strain D14. Deleting the IMD
genes, which are redundant among them and showed increased CN, can be a complex approach
(around 10–14 copies can be found, 2 of each IMD1-4 gene and extra copies depending on the
strain). Instead of we selected gene GUA1 of D14, because Gua1p catalyzes the subsequent step
of the Imd enzymes, and because no increased copy numbers of GUA1 exist in D14. In fact, and
as expected, the deletion of two GUA1 copies in the diploid strain D14 led to a GUA1 knock out
mutant (D14Δgua1). We also constructed a reconstituted GUA1 (D14GUA1) strain as a control
by transforming the D14Δgua1 mutant with an episomal plasmid containing GUA1.
Next, we evaluated the virulence of these two strains and the wild-type D14 in murine infec-
tion models (Fig. 3). Since S. cerevisiae infections have been described mainly in immunode-
ficient patients, we used a mice model of systemic infection with cyclophosphamide-induced
neutropenia, which has been previously been used in S. cerevisiae and in other pathogenic organ-
isms such as C. albicans [16], [24], [32]. The results revealed that only 15% of mice infected with
strain D14 survive until day 22, whereas D14Δgua1 was unable to cause death in the mice. The
GUA1-reconstituted strain caused a similar pattern (no significantly different, p-value<0.05) of
mice survival as compared to the parental strain, but was moderately reduced in virulence (50%
survival of mice). On the contrary, The GUA1-reconstituted strain and D14Δgua1 strain were
significantly different (p-value<0.05) to the wild type strain.
Fig 3. Virulence implication in S. cerevisiae opportunistic strain D14 of theGUA1 gene.GUA1 encodes
an essential enzyme of de novo biosynthesis of purine nucleotides pathway in immunocompromisedmurine
models. DBA/2 healthy mice (8 for each strain) were intravenous inoculated with the corresponding yeast strain
and survival was followed every day. Mouse immunodeficiency was produced by intraperitoneal injections of
cyclophosphamide (150mg/kg) at day -1 and 5 after yeast infection. Kaplan-Meyer curves were represented.
TheGUA1-reconstituted strain survival was no significantly different (p-value<0.05) to the parental strain, but
theGUA1-reconstituted strain and D14Δgua1 strain were significantly different (p-value<0.05) to the
parental strain.
doi:10.1371/journal.pone.0122382.g003
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Decreased survival in D14Δgua1 mice can be a consequence of low guanine levels in the
host. However, an increased dNTP pool which could be used for DNA repair. An increased
DNA repair may be required during systemic infections since oxidative damage of yeast DNA
is one of the key events which occur after blood infection. To test this hypothesis, we studied
yeast growth in the presence of mycophenolic acid (MPA), an inhibitor of Imd enzymes. In
fact, the expression of IMD genes is induced by mycophenolic acid to result in resistance to the
drug [23], [33], [34]. The results (Fig. 4A) reveal that the opportunistic strains are able to grow
in the presence of 7 μg/ml of MPA, whereas the growth of laboratory strains S288C andW303
was strongly affected. These results phenotypically confirm the predictions made based on the
CGH and qPCR data. Next, we tested the growth of the strains in the presence of the DNA
damaging agent methyl methanesulfonate (MMS), which produces alkylated DNA that is
poorly replicated by DNA polymerases and must be efficiently repaired. We observed that the
laboratory yeast strains S288c or W303 were highly sensitive to MMS (0.004%) treatment,
whereas the opportunistic yeasts strains were much less affected (Fig. 4).
In order to study the role of the novo purine nucleotide biosynthesis pathway when yeast
cells face human phagocytes, we quantified fungal survival after ex vivo human blood infection
when neutrophils attack yeast cells and produce reactive oxygen species. We studied yeast sur-
vival after 90 min of blood incubation by colony counting on rich media. This experimental set
up was already used to show increased survival of opportunistic yeasts compared to other
Fig 4. The critical role of genes related to dNTP pool increase in response to human blood
phagocytes. A) Evaluation of yeast performance in response to 7 μg/ml of mycophenolic acid (MPA) or
0.004% of MMS was compared to control minimal media SC for opportunistic strains D14, 102 and 60 and for
control lab strains S288C andW303. B) Evaluation of yeast survival after 90 min of ex vivo human blood
incubation. After blood incubation, wild type lab strains BY4741 andW1588-4C and D14 opportunistic strain
were plated in YPD or YPD with guanine (65 μM) and colony were counted. C) Also, dun1 and rnr1*mutants
were plated in YPD after blood exposure. Triplicates average and standard deviation of normalized survival
data (YPD + guanine respect YPD and mutants respect its isogenic parental wild type) is represented. In all
cases (control respect guanine and mutants respect to wild type) differences were significantly different using
p-value of 0.05.
doi:10.1371/journal.pone.0122382.g004
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strains in blood infections [25]. Here we observed that addition of guanine to rich media in-
creased survival in the opportunistic strain D14, but also in the laboratory wild-type strains
BY4741 and W1588 (selected to compare with their isogenic mutants, see below) (Fig. 4B). In
order to ensure that increased survival was not due to an additional and more efficient nitrogen
source, we performed the same experiment adding the equivalent amount of nitrogen. Howev-
er, no increased survival of yeast cells was found (data not shown). In this assay, we also ana-
lyzed the behavior of two mutants with lower dNTP levels due to mutation of genes which
influence the expression of the last enzyme of the dNTP biosynthetic pathway, ribonucleotide
reductase (RNR). One mutant tested was Δdun1, which lacks the DUN1 gene. DUN1 encodes a
key activator of RNR in response to DNA damage. The Δdun1mutant was previously shown
to have dysfunctions in RNR activation and decreased dNTP pools after DNA damage [34],
[35]. The other mutant tested was rnr1, containing a point mutation that disrupts RNR activa-
tion in response to DNA damage [19]. The results (Fig. 4B) indicate that both mutants were
less able to survive in human blood as compared to their isogenic parental wild type strains. Es-
pecially rnr1 had a strongly (more than 70%) reduced ability to survive the challenge of blood
cells. These data suggest that de novo dNTP biosynthesis plays a role in yeast survival after
DNA damage produced by neutrophils or other blood cells.
Discussion
To elucidate the genetic determinants that enable certain strains of S. cerevisiae to cause infec-
tion, we used a comparative genetics approach. We compared the genomes of strains showing
high level of virulence attributes (pseudohyphal and 42°C growth, phosphatases and proteases
secretion, and the ability to infect and kill mice) independently of the isolation origin [13],
[16], [18] with the gene content of non-virulent laboratory strains using microarrays. Many
strains of S. cerevisiae which have been isolated in clinical settings present very low levels of vir-
ulence in mice infection models and other strains, such as strain D14, isolated from a dietetic
supplement, show a relative high level of virulence in different infection models. Thus, we pro-
pose that the term “opportunistic strain” is more accurate and useful to categorize these strains
rather than “clinical strains”, since not all clinical strains cause infections. We define opportu-
nistic S. cerevisiae strains as those strains which can, in contrast to most other strains, cause in-
fections in mice and can kill mice. These strains also survive better in human blood infection
models than other strains, which may enable these strains to disseminate across the body and
to reach organs with adequate propagation conditions under certain circumstances [25]. Thus,
increased blood survival can be a key feature to distinguish these opportunistic yeasts strains
from others. Previous studies by our group have demonstrated that opportunistic strains show
a specific transcription pattern after human blood infection, which indicate a specific oxidative
stress response and DNA damage repair [25]. DNA damage is apparently produced by reactive
oxygen species generated mainly by neutrophils and a proper DNA repair may be a specific
characteristic of opportunistic strains. In this study, we aimed at further characterizing these
strains by using a genomic approach.
A common mechanism described for human microbial pathogens is to increase dNTP
pools in order to repair DNA damage caused by the oxidative burst of phagocytes. For example,
the importance of a de novo nucleotide biosynthetic pathway for phagocyte survival has been
demonstrated for bacterial pathogens such as Salmonella enterica [36], Bacteroides fragilis [37],
Pseudomonas aeruginosa [38], Staphylococcus aureus [39], Streptococcus pyogenes [40], Bacillus
anthracis and Escherichia coli [41]. The relevance of de novo nucleotide biosynthetic pathways
has also been implicated for fungal pathogens like Cryptococcus neoformans [42] or Candida
albicans [43], [44] and nucleotide biosynthetic pathways have been discussed as a target for
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antifungal compounds [45]. The results obtained in our study highlight a specific genomic fin-
gerprint of opportunistic strains that increase the gene copy number of genes involved in the
de novo biosynthesis of purine nucleotides. We conclude that S. cerevisiae opportunistic strains,
like other human pathogens, have the enhanced ability to produce dNTPs, the substrates that
are used by DNA repair machineries. This is supported by the observation that mutantsΔdun1
and rnr, which showed lower dNTP pools and defects in RNR activation after DNA damage
[19], [34], [35], display poorer survival in human blood as compared to wild type strains.
Other genes involved in DNA repair are also highlighted by our CGH study. One interesting
example is IMP2, a transcription factor gene, which is activated in response to DNA damage
produced by oxidative stress and which regulates the expression of DNA repair genes. Thus, an
enhanced dNTP production pathway combined with efficient DNA repair machinery may be a
key feature to define opportunistic S. cerevisiae yeasts. Our study opens up the possibility the
de novo purine biosynthetic pathway is a possible alternative target to treat S. cerevisiae infec-
tions, as previously proposed for other fungal pathogens such as C. albicans [43–45].
In general terms, increased dNTP biosynthesis to supply DNA repair seems to be a general
strategy used by some pathogens to survive human macrophages oxidative burst. However,
those genes that have been shown to be associated with virulence differ among the different
organisms. The role of Imd activity, which is the rate-limiting step in the de novo purine bio-
synthetic pathway, has been stressed in the fungal pathogen C. neoformans [42]. In C. albi-
cans, other genes, or genes associated with the same pathway, for example ADE2, ADE7 or
GUA1, have also been implicated in virulence [43], [44]. In contrast, studies dealing with bac-
terial pathogens have proposed that RNR activity is most important, since it is the key rate-
limiting step in deoxyribonucleotides formation [37–39]. Here we propose that both IMD
genes and RNR are important for opportunistic yeasts to cause infections. The fact that oppor-
tunistic yeasts have increased IMD gene copy numbers suggests that the level of such activity
is crucial, although we also observed that diminished RNR activity dramatically affects surviv-
al in blood infections. Therefore, both activities, Imd and RNR, influence the ability of oppor-
tunistic S. cerevisiae strains to overcome an oxidative burst attack by phagocytes and to
survive at least transiently in blood. This property may enable these strains to reach other or-
gans and to proliferate.
New knowledge on opportunistic yeast is essential to understand the intrinsic differences
between these strains and the standard strains used in the food industry considered safe. This
will help in the selection of strains that are suitable to produce foods. Some criteria has been
previously suggested to avoid opportunistic yeast in foods as growth above 37°C [46], [47] or
increased oxidative stress resistance [25]. Here we propose new criteria to discard opportunis-
tic strains for the food industry: increased resistance to DNA damage agents or increased resis-
tance to de novo dNTP biosynthesis inhibitors. A combination of all this criteria will be useful
to select safer strains for the production of human foods.
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